An unconfirmed report is circulating that acting-commissioner at the US Food and Drug Administration Andrew Von Eschenbach is to be nominated by US President George W Bush to assume the position on a permanent basis. The appointment would need to be confirmed by the US Senate.
The story appeared on Peter Pitts' Drugwonks.com blog. Mr Pitts is a former FDA Associate Commissioner for External Relations and currently Senior Fellow for health care studies at the San Francisco, USA-based think tank, the Pacific Research Institute.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze